Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etonogestrel Implant in Women With Sickle Cell Disease
NCT02594462Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2015
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of etonogestrel in sickle cell anemia (SCA), sponsored by Universidade de São Paulo. Started Jan 2015; status: completed.
02
Drugs
etonogestrel
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT02594462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02594462.